The results of this study collectively suggest that miR-518f-5p is capable of modulating CD9 expression and increases non-tumorigenic breast and breast cancer cell migration in vitro and that loss of CD9 in vivo affects tumorigenesis. Here, CD9 is linked to breast carcinoma.